Neonatal effects of exposure to selective serotonin reuptake inhibitors during pregnancy [1]

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 91, Issue 2, 2006, Pages

  Bot, P ^a   Semmekrot, B A ^a   Van Der Stappen, J ^a  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLORAZEPATE; FLUOXETINE; OXCARBAZEPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ANAMNESIS; CLINICAL ARTICLE; CLINICAL FEATURE; DEPRESSION; EEG ABNORMALITY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPOTHERMIA; INFANT; IRRITABILITY; LETTER; MALE; MUSCLE HYPERTONIA; MUSCLE HYPOTONIA; MYOCLONUS; PREGNANCY; PRIORITY JOURNAL; RESTLESSNESS;

FEMALE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; NEONATAL ABSTINENCE SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS;

EID: 33644658395     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2004.066431     Document Type: Letter

References (6)

1. Nordeng H, Lindemann R, Perminov KV, et al. Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 2001;90:288-91.
2. Nijhuis U, Kok-Van Rooij GW, Bosschaart AN. Withdrawal reactions of a premature neonate after maternal use of paroxetine. Arch Dis Child Fetal Neonatal Ed 2001;84:F77.
3. Stiskal JA, Kulin N, Koren G, et al. Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 2001;84:F134-5.
4. Zeskind PS, Stephens LE. Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004;113:368-75.
5. Isbister GK, Dawson A, Whyte IM, et al. Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Arch Dis Child Fetal Neonatal Ed 2001;85:F147-8.
6. Sanz EJ, De-las-Cuevas C, Kiuru A, et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 2005;365:482-7.